B. Metzler seel. Sohn & Co’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-49,037
Closed -$277K 756
2023
Q4
$277K Buy
49,037
+15,899
+48% +$89.8K ﹤0.01% 692
2023
Q3
$61.6K Sell
33,138
-33,138
-50% -$61.6K ﹤0.01% 723
2023
Q2
$182K Buy
66,276
+48,156
+266% +$132K ﹤0.01% 725
2023
Q1
$56.9K Buy
+18,120
New +$56.9K ﹤0.01% 726
2022
Q4
Sell
-14,700
Closed -$129K 725
2022
Q3
$129K Buy
+14,700
New +$129K ﹤0.01% 724